• Order to parcel locker

    Order to parcel locker
  • easy pay

    easy pay
  • Reduced price
Mast Cell Disorders, An Issue of Immunology and Allergy Clinics of North America

Mast Cell Disorders, An Issue of Immunology and Allergy Clinics of North America

9780443181832
PRINT ON DEMAND - DELIVERY CAN TAKE UP TO 14 DAYS
493.23 zł
419.25 zł Save 73.98 zł Tax included
Lowest price within 30 days before promotion: 419.25 zł
Quantity
Available in 4-6 weeks

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description
In this issue of Immunology & Allergy Clinics, guest editor Dr. Cem Akin brings his considerable expertise to the topic of Mast Cell Disorders. Top experts in the field provide readers with information on the identification, management, and treatment of mast cell disorders and mastocytosis.
Product Details
Elsevier
99417
9780443181832
9780443181832

Data sheet

Publication date
2023
Issue number
1
Cover
hard cover
Pages count
240
Dimensions (mm)
151 x 229
Weight (g)
430
  • World Health Organization Classification and Diagnosis of Mastocytosis: Update 2023 and Future Perspectives
    KIT Mutations and Other Genetic Defects in Mastocytosis: Implications for Disease Pathology and Targeted Therapies
    Pediatric and Hereditary Mastocytosis
    Management of Mediator Symptoms, Allergy, and Anaphylaxis in Mastocytosis
    Drug and Venom Allergy in Mastocytosis
    Gastrointestinal Disease in Mastocytosis
    Management of Advanced Systemic Mastocytosis and Associated Myeloid Neoplasms
    Tyrosine Kinase Inhibitors in Non-advanced Systemic Mastocytosis
    Measuring Symptom Severity and Quality of Life in Mastocytosis
    Effect of Gender and Special Considerations for Women in Mastocytosis and Anaphylaxis
    Update on Mast Cell Proteases as Drug Targets
Comments (0)